United States securities and exchange commission logo




                                                                                
                          February 23, 2024

       Francois Michelon
       Chief Executive Officer
       ENDRA Life Sciences Inc.
       3600 Green Court, Suite 350
       Ann Arbor, MI 48105

                                                        Re: ENDRA Life Sciences 
Inc.
                                                            Registration 
Statement on Form S-3
                                                            Filed February 14, 
2024
                                                            File No. 333-277058

       Dear Francois Michelon:

              This is to advise you that we have not reviewed and will not 
review your registration
       statement.

               Please refer to Rules 460 and 461 regarding requests for 
acceleration. We remind you
       that the company and its management are responsible for the accuracy and 
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of 
action by the staff.

                                                        Please contact Benjamin 
Richie at 202-551-7857 with any questions.



                                                                                
                          Sincerely,

                                                                                
                          Division of Corporation Finance
                                                                                
                          Office of Industrial Applications and
                                                                                
                          Services
       cc:                                              Coleman Wombwell